The favoured treatment of common bile duct stones is endoscopic sphincterotomy and stone extraction. The management of those cases where duct clearance is not possible is controversial. At our institution it has been policy to insert an endoluminal stent. We report a retrospective review of the outcome of patients stented for common bile duct stones. The study population was 14 men and 22 women, with a median age of 73 years (range 23-89 years). Treatment-related morbidity was seen in nine patients (25%), comprising cholangitis (5), pancreatitis (3), and cholecystitis (1). Three of these patients died; all were over the age of 75 years and had been stented on a long-term basis. These data suggest that endobiliary stents can be employed with an acceptable complication rate. We suggest that patients under the age of 75 years be stented only as a temporising measure, but that patients over 75 years or those unfit on physiological grounds can be stented on a long-term basis as definitive treatment.
Summary
The favoured treatment of common bile duct stones is endoscopic sphincterotomy and stone extraction. The management of those cases where duct clearance is not possible is controversial. At our institution it has been policy to insert an endoluminal stent. We report a retrospective review of the outcome of patients stented for common bile duct stones. The study population was 14 men and 22 women, with a median age of 73 years (range 23-89 years). Treatment-related morbidity was seen in nine patients (25%), comprising cholangitis (5), pancreatitis (3) , and cholecystitis (1) . Three of these patients died; all were over the age of 75 years and had been stented on a long-term basis. These data suggest that endobiliary stents can be employed with an acceptable complication rate. We suggest that patients under the age of 75 years be stented only as a temporising measure, but that patients over 75 years or those unfit on physiological grounds can be stented on a long-term basis as definitive treatment.
Keywords: common bile duct calculi; stents Up to 15% of patients with cholelithiasis are affected by stones within the common bile duct.1 Prior to the advent of endoscopic retrograde cholangiopancreatography (ERCP) the management comprised surgical exploration of the common bile duct.2 Many of these patients are elderly and have comorbidity, making surgery and anaesthesia hazardous."' Further, these patients are compromised as a result of sepsis and jaundice secondary to the underlying biliary tract obstruction.
Currently, the favoured therapeutic modality is endoscopic sphincterotomy and stone extraction. Ideally, the common bile duct should be left free of stones at the initial endoscopic procedure. This is achieved in over 80% of patients.9"' Retained stones following the initial endoscopic procedure are associated with a three-fold excess of complications. 3"'5 Management of such cases of incomplete common bile duct clearance is controversial. At our institution it has been policy to employ endoluminal stents in such cases. The study was a retrospective review of the outcome of patients stented for common bile duct stones. 
Methods

Results
During the study period 204 ERCPs for choledocholithiasis were performed. Duct clearance was achieved at the initial procedure in 165 patients (81%). In 39 patients this was not feasible and a stent was deployed. Complete data were available on 36 of these 39 patients. The study group comprised 14 men and 22 women, with a median age of 73 years (range 23-89). Fifteen of the 36 (42%) were over the age of 75. The median follow-up time for the group was 12.5 months (range 0.5-36) with stents being left in-situ for a median time of 5 months (range 0.5-36). The minimum follow-up time was 6 months (excepting those patients dying prior to this time). Twenty-three of the patients had common bile duct stones of 1.0 cm or greater diameter, and in 18 patients the duct contained multiple stones.
Based upon the intention of treatment (see table 1), 18 patients had a stent placed as a temporising measure. In the remaining 18 patients the stent was deployed as definitive therapy; these patients were considered 
